IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — PRAX

Balance Sheet

(in billions USD)
MetricQ1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.540.150.160.170.170.150.150.100.120.080.060.060.080.170.180.13
Short-term Investments0.25------------------------------
Total Current Assets0.800.270.310.330.360.360.210.100.130.090.130.180.230.320.350.28
Property, Plant & Equipment0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Non-current Assets*0.660.120.150.150.060.080.040.000.000.000.000.000.010.010.010.00
Total Assets1.460.400.450.480.420.440.250.110.130.100.140.180.240.320.350.28
Accounts Payable0.030.030.030.020.020.010.010.010.010.020.010.010.010.010.010.01
Total Current Liabilities0.050.050.050.040.030.020.020.020.020.030.030.040.050.020.020.01
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities0.050.050.050.040.030.020.020.020.030.030.030.040.050.030.020.01
Retained Earnings(1.23)(1.05)(0.98)(0.91)(0.78)(0.73)(0.69)(0.63)(0.60)(0.57)(0.49)(0.45)(0.39)(0.26)(0.21)(0.18)
Total Stockholder Equity1.410.340.400.440.380.420.230.090.110.060.110.140.190.300.330.27

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Total Revenue--0.000.000.000.007.460.300.360.430.520.470.780.68--------------
Research & Development77.9977.5165.8063.0160.8156.2941.8827.2626.9818.3917.2625.6125.5028.3330.4443.6252.6543.5133.1425.68
Selling, General & Admin27.8719.5412.5613.0613.9215.1315.2610.5915.339.938.7210.1313.2713.1213.8516.7716.2015.1511.6310.81
Total Operating Expenses105.8697.0478.3676.0774.7371.4257.1437.8542.3228.3225.9835.7438.7741.4544.2960.3968.8558.6644.7736.48
Operating Income(105.86)(97.04)(78.36)(76.07)(74.73)(63.96)(56.83)(37.49)(41.89)(27.81)(25.52)(34.96)(38.09)(41.45)(44.29)(60.39)(68.85)(58.66)(44.77)(36.48)
Pretax Income----------------------------(43.94)----(58.59)(44.70)(36.40)
Tax Provision----------------------------0.00-----0.000.010.00
Net Income(92.56)(88.91)(73.93)(71.13)(69.30)(58.68)(51.91)(32.68)(39.55)(26.88)(24.63)(34.31)(37.45)(41.17)(43.94)(60.19)(68.72)(58.58)(44.70)(36.40)
Basic EPS(3.20)(3.52)(3.36)(3.31)(3.29)(2.88)(2.75)(1.74)(2.84)(17.31)(0.18)(0.49)(0.71)(0.85)(0.96)(1.32)(1.51)(1.33)(1.00)(0.88)
Diluted EPS(3.20)(3.52)(3.36)(3.31)(3.29)(2.88)(2.75)(1.74)(2.84)(17.31)(0.18)(0.49)(0.71)(0.85)(0.96)(1.32)(1.51)(1.33)(1.00)(0.88)

Cash Flow Statement

(in millions USD)
MetricQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Operating Cash Flow(86.15)(76.32)(65.06)(54.68)(53.01)(56.12)(27.50)(27.28)(20.86)(23.86)(23.21)(31.21)(32.85)(28.81)(44.92)(57.21)(54.11)(44.86)(23.96)(30.01)
Capital Expenditures0.060.000.000.06----------0.050.000.000.000.000.050.110.290.530.000.07
Free Cash Flow*(86.21)(76.32)(65.06)(54.73)----------(23.91)(23.21)(31.21)(32.85)(28.81)(44.96)(57.32)(54.40)(45.39)(23.96)(30.08)
Investing Cash Flow(344.27)(328.39)50.4117.89(51.06)(10.92)49.57(195.92)(91.22)(0.05)0.005.0034.0022.5947.9634.89(8.55)10.1713.55(24.23)
Financing Cash Flow609.43612.526.7628.6354.27113.771.44216.36182.764.130.0069.6818.075.393.370.501.217.710.2199.39

* Derived from reported values